. | Diabetes duration (years) . | Age at onset (months) . | Mutation . | Sex . | Antibody at onset . | Islet cell antibodies (N<5JDF) . | GAD anitbody (N<9.1 IU/ml) . | Insulin-associated protein 2 antibody (N<20 IU/ml) . |
---|---|---|---|---|---|---|---|---|
Pol2 | 13 | 1 | R201H | M | 0 | 0 | 9.4 | 159.5 |
Pol9 | 20 | 3 | V59M | F | NA | 0 | 0.0 | 0.0 |
Pol11 | 22 | 2 | K170N | F | NA | 10 | 4.0 | 67.8 |
Pol13 | 35 | 2 | R201H | F | NA | 0 | 1.8 | 16.4 |
Pol14 | 21 | 3 | R201H | F | NA | 0 | 1.9 | 17.3 |
Pol16 | 5 | 1 | V59M | M | 0 | 0 | 0.0 | 0.0 |
Pol19 | 50 | 3 | R201H | M | NA | 40 | 1.1 | 20.8 |
Pol23 | 6 | 3 | H46L | F | 0 | 0 | 6.3 | 10.3 |
Pol31 | 11 | 2 | E229K | M | 0 | 10 | 3.6 | 7.6 |
Pol32 | 19 | 1 | G53D | M | 0 | 0 | 0.0 | 59.0 |
Pol33 | 11 | 2 | R201H | F | 0 | 0 | 0.2 | 0.0 |
. | Diabetes duration (years) . | Age at onset (months) . | Mutation . | Sex . | Antibody at onset . | Islet cell antibodies (N<5JDF) . | GAD anitbody (N<9.1 IU/ml) . | Insulin-associated protein 2 antibody (N<20 IU/ml) . |
---|---|---|---|---|---|---|---|---|
Pol2 | 13 | 1 | R201H | M | 0 | 0 | 9.4 | 159.5 |
Pol9 | 20 | 3 | V59M | F | NA | 0 | 0.0 | 0.0 |
Pol11 | 22 | 2 | K170N | F | NA | 10 | 4.0 | 67.8 |
Pol13 | 35 | 2 | R201H | F | NA | 0 | 1.8 | 16.4 |
Pol14 | 21 | 3 | R201H | F | NA | 0 | 1.9 | 17.3 |
Pol16 | 5 | 1 | V59M | M | 0 | 0 | 0.0 | 0.0 |
Pol19 | 50 | 3 | R201H | M | NA | 40 | 1.1 | 20.8 |
Pol23 | 6 | 3 | H46L | F | 0 | 0 | 6.3 | 10.3 |
Pol31 | 11 | 2 | E229K | M | 0 | 10 | 3.6 | 7.6 |
Pol32 | 19 | 1 | G53D | M | 0 | 0 | 0.0 | 59.0 |
Pol33 | 11 | 2 | R201H | F | 0 | 0 | 0.2 | 0.0 |
F, female; M, male; N, normal value.